Trigen Laboratories' Financial Acquisition

Trigen Laboratories raised a round of funding on December 16, 2013. Investors include Avista Capital Partners.

Trigen Laboratories is a generic pharmaceutical company offering unique products across an increasing array of categories. Trigen seeks to bring value-driven generic products to its customers, workin…

Articles about Trigen Laboratories' Financial Acquisition: